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First things first: Protecting children with asthma from infection 
with influenza
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Currently in the U.S., approximately 7 million children (9.4%) have asthma (1), making it 
the most prevalent serious chronic illness among U.S. children. Clinically, the association of 
viral respiratory infections and asthma exacerbations has been understood for decades. More 
recently, infections with particular viruses have been identified as being particularly risky: 
respiratory syncytial virus, rhinovirus, and influenza virus are notable examples. In the 
spring of 2009, a new influenza virus (A(H1N1)pdm09 [2009 H1N1]) with pandemic 
potential was isolated from patients in the U.S. and around the world (2). Early data 
indicated that certain comorbid medical conditions increased the risk for hospitalization and 
intensive care unit admission (3). Persons with asthma appeared to bear a disproportionate 
risk, and local and state health departments along with Centers for Disease Control and 
Prevention (CDC) developed and disseminated guidance early in the outbreak for persons 
with asthma and their health care providers. Early diagnosis and use of antiviral medication, 
along with public health practices like self-distancing and hand-washing, were emphasized. 
Persons with comorbid conditions (including asthma) were prioritized to receive vaccine 
once it became available. These recommendations, however, were more re-iterations of 
existing practices and policies rather than de novo interventions. As was consistent with 
previous recommendations, vaccination of persons with asthma was to prevent influenza 
because of the risk of increased disease severity, rather than increased risk of becoming 
infected with influenza virus. Analysis of existing data did not, at that point in time, support 
(nor refute) an increased risk of infection among persons with asthma.
In this issue of American Journal of Respiratory and Critical Care Medicine, Kloepfer and 
co-authors demonstrated an increased risk of infection with 2009 H1N1 influenza virus 
among persons with asthma. The opportunity to collect the data to demonstrate this finding 
was serendipitous: the authors had a well-planned, ongoing study of viral respiratory 
infection and asthma at the time the fall wave of the 2009 outbreak arrived in their locale. 
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The study protocol was modified to include the new influenza virus, permitting the 
collection of the data needed to show not only increased risk of worse clinical outcomes, but 
of influenza infection itself. This finding strengthens the recommendations of the Advisory 
Committee on Immunization Practices (ACIP), the National Asthma Education and 
Prevention Program (NAEPP), and CDC for routine influenza vaccination among persons 
with asthma.
The authors were not able to demonstrate the cause of the increased risk of infections; 
hypotheses include altered immune status related to asthma, lessened local cell-mediated 
immune response from inhaled corticosteroids (which, however, remain the bedrock of most 
asthma care, and good asthma control going into cold & flu season is essential for this 
population), co-infections or other comorbidities, among other possibilities. Why had data 
from previous studies not been able to demonstrate this finding? Most previous data on 
influenza vaccination is obtained by retrospective report, such as in the Behavioral Risk 
Factor Surveillance System (BRFSS) and the National Health Interview Survey (NHIS). Of 
course, a prospective study that involved withholding vaccination would be unethical. 
However, in 2009 a novel viral strain (2009 H1N1) was identified after trivalent (seasonal) 
production started and required 2009 H1N1 monovalent vaccine as an additional vaccine to 
that year’s 2009–10 trivalent (seasonal) vaccine. This natural experiment, in conjunction 
with the authors’ existing prospective study, allowed the question of increased risk of 
infection to be answered.
Unfortunately, influenza vaccination coverage among persons with asthma remains low—
under 40% overall, except in persons aged 65 or over—each influenza season, including 
during the 2009 pandemic flu episode that began in 2009 (1). Although an increased number 
of health-care visits is associated with increased likelihood of vaccination, the same data 
more starkly demonstrate the missed opportunities for vaccination: even among persons with 
asthma who had ≥ 10 health-care visits during the influenza vaccination season, only 50% 
received the seasonal vaccination in 2005–06 (4). A similar study using the BRFSS dataset 
for the 2006–07 found that among adults with asthma, only 39.9% received the influenza 
vaccine. People with asthma who had an increased likelihood of vaccination were aged 50–
64 years, female, non-Hispanic white, and had diabetes, activity limitations, medical 
insurance, a regular medical care provider, routine checkup in the previous year, and 
formerly smoked or never smoked. Additionally, the 2009 H1N1 vaccination coverage 
among adults with asthma was only 25.5% (5).
Although the authors in the current study answer an important, previously unanswered 
question, the essential question remains: why are persons with asthma not receiving flu 
shots? Even more broadly, why are persons with asthma not on treatment programs 
consistent with the NAEPP EPR-3 guidelines? When the most recent version of the 
guidelines was published in 2007, the NAEPP provided the following guidance: The Expert 
Panel recommends that clinicians consider inactivated influenza vaccination for patients 
who have asthma. It is safe to administer in children over 6 months and adults who have 
asthma (Evidence A), and the Advisory Committee on Immunization Practices of the CDC 
recommends the vaccine for persons who have asthma because they may be at increased 
risk for complications from influenza (6). To be consistent with the ACIP, these guidelines 
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should be strengthened to recommend influenza vaccination for all patients with asthma 
because they are at increased risk for complications from asthma. Nevertheless, 
recommendations for influenza vaccine and other key recommendations, such as “inhaled 
corticosteroids are the most effective anti-inflammatory medications for long-term 
management of persistent asthma,” and “all people with asthma should receive a written 
Asthma Action Plan,” have similarly low uptake among patients with asthma.
The concept of translational research—moving bench science to bedside—must go hand-in-
hand with translational public health, i.e., moving evidence-based guidelines into routine 
practice. Kloepfer and co-authors add to the evidence supporting influenza vaccination of 
children with asthma; we now need to routinely provide influenza vaccination to our patients 
with asthma. Persons with asthma are recommended to have routine follow-up visits at 1 to 
6 month intervals to ensure that control of asthma is maintained. These follow-up physician 
visits can provide important opportunities for physicians to vaccinate persons with asthma or 
to remind them that they need to get an influenza vaccination. Additionally, offering 
influenza vaccination in the emergency room (ER) to those with asthma would be 
appropriate. Sometimes that is the only place these patients are seen.
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